Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial

“As a clinician, I really want to see that long-term data before switching my practice to BVS because we have been burnt in the past before, switching to newer devices without longer-term data.”